Justin R Hamilton

Summary

Affiliation: Monash University
Country: Australia

Publications

  1. ncbi Antiplatelet therapy: present status and future prospects
    Justin R Hamilton
    Australian Centre for Blood Diseases, Monash University, 6th Level, Burnet Building, AMREP Campus, 89 Commercial Road, Melbourne, Victoria 3004, Australia 61 3 9903 0122 61 3 9903 0228
    Expert Opin Drug Discov 2:1035-40. 2007
  2. ncbi Essential role of platelet activation via protease activated receptor 4 in tissue factor-initiated inflammation
    Nathalie Busso
    Laboratoire de Rhumatologie, Centre Hospitalier Universitaire Vaudois, 1011 Lausanne, Switzerland
    Arthritis Res Ther 10:R42. 2008
  3. ncbi Protease-activated receptors as targets for antiplatelet therapy
    Justin R Hamilton
    Australian Centre for Blood Diseases, Monash University L6, 89 Commercial Road, Melbourne, Victoria 3004, Australia
    Blood Rev 23:61-5. 2009
  4. ncbi Atherosclerosis proceeds independently of thrombin-induced platelet activation in ApoE-/- mice
    J R Hamilton
    Australian Centre for Blood Diseases, Monash University, Melbourne, Vic, Australia
    Atherosclerosis 205:427-32. 2009
  5. ncbi The contribution of thrombin-induced platelet activation to thrombus growth is diminished under pathological blood shear conditions
    Hannah Lee
    Australian Centre for Blood Diseases, Monash University, Melbourne, Victoria, Australia
    Thromb Haemost 107:328-37. 2012
  6. ncbi Identification of a fibrin-independent platelet contractile mechanism regulating primary hemostasis and thrombus growth
    Akiko Ono
    Australian Centre for Blood Diseases, Monash University, Melbourne, Australia
    Blood 112:90-9. 2008
  7. ncbi Physiology, pharmacology, and therapeutic potential of protease-activated receptors in vascular disease
    Hannah Lee
    Australian Centre for Blood Diseases, Monash University, Melbourne, Australia
    Pharmacol Ther 134:246-59. 2012

Collaborators

Detail Information

Publications7

  1. ncbi Antiplatelet therapy: present status and future prospects
    Justin R Hamilton
    Australian Centre for Blood Diseases, Monash University, 6th Level, Burnet Building, AMREP Campus, 89 Commercial Road, Melbourne, Victoria 3004, Australia 61 3 9903 0122 61 3 9903 0228
    Expert Opin Drug Discov 2:1035-40. 2007
    ..This perspective focuses on the present state of antiplatelet therapy and potential future strategies to improve the safety and efficacy of antiplatelet agents...
  2. ncbi Essential role of platelet activation via protease activated receptor 4 in tissue factor-initiated inflammation
    Nathalie Busso
    Laboratoire de Rhumatologie, Centre Hospitalier Universitaire Vaudois, 1011 Lausanne, Switzerland
    Arthritis Res Ther 10:R42. 2008
    ....
  3. ncbi Protease-activated receptors as targets for antiplatelet therapy
    Justin R Hamilton
    Australian Centre for Blood Diseases, Monash University L6, 89 Commercial Road, Melbourne, Victoria 3004, Australia
    Blood Rev 23:61-5. 2009
    ..This review outlines the role of platelet PARs in haemostasis and thrombosis and discusses the preclinical and clinical evidence supporting the potential of PAR antagonists as novel antiplatelet therapy...
  4. ncbi Atherosclerosis proceeds independently of thrombin-induced platelet activation in ApoE-/- mice
    J R Hamilton
    Australian Centre for Blood Diseases, Monash University, Melbourne, Vic, Australia
    Atherosclerosis 205:427-32. 2009
    ....
  5. ncbi The contribution of thrombin-induced platelet activation to thrombus growth is diminished under pathological blood shear conditions
    Hannah Lee
    Australian Centre for Blood Diseases, Monash University, Melbourne, Victoria, Australia
    Thromb Haemost 107:328-37. 2012
    ....
  6. ncbi Identification of a fibrin-independent platelet contractile mechanism regulating primary hemostasis and thrombus growth
    Akiko Ono
    Australian Centre for Blood Diseases, Monash University, Melbourne, Australia
    Blood 112:90-9. 2008
    ..Furthermore, they provide new insight into the underlying bleeding diathesis associated with platelet contractility defects...
  7. ncbi Physiology, pharmacology, and therapeutic potential of protease-activated receptors in vascular disease
    Hannah Lee
    Australian Centre for Blood Diseases, Monash University, Melbourne, Australia
    Pharmacol Ther 134:246-59. 2012
    ....